Australia Analgesics Market Size & Outlook, 2022-2030

The analgesics market in Australia is expected to reach a projected revenue of US$ 1,145.0 million by 2030. A compound annual growth rate of 7.7% is expected of Australia analgesics market from 2023 to 2030.
Revenue, 2022 (US$M)
$633.8
Forecast, 2030 (US$M)
$1,145.0
CAGR, 2023 - 2030
7.7%
Report Coverage
Australia

Australia analgesics market highlights

  • The Australia analgesics market generated a revenue of USD 633.8 million in 2022 and is expected to reach USD 1,145.0 million by 2030.
  • The Australia market is expected to grow at a CAGR of 7.7% from 2023 to 2030.
  • In terms of segment, non-opioid was the largest revenue generating drug type in 2022.
  • Compound Medication is the most lucrative drug type segment registering the fastest growth during the forecast period.


Analgesics market data book summary

Market revenue in 2022USD 633.8 million
Market revenue in 2030USD 1,145.0 million
Growth rate7.7% (CAGR from 2022 to 2030)
Largest segmentNon-opioid
Fastest growing segmentCompound Medication
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationOpioid, Non-opioid, Compound Medication
Key market players worldwideBayer AG, Assertio Holdings Inc, Johnson & Johnson, GSK PLC, AbbVie Inc, Novartis AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd


Other key industry trends

  • In terms of revenue, Australia accounted for 1.6% of the global analgesics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China analgesics market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,832.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Analgesics Market Companies

Name Profile # Employees HQ Website

Australia analgesics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to analgesics market will help companies and investors design strategic landscapes.


Non-opioid was the largest segment with a revenue share of 51.39% in 2022. Horizon Databook has segmented the Australia analgesics market based on opioid, non-opioid, compound medication covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Australia analgesics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia analgesics market databook

  • Our clientele includes a mix of analgesics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia analgesics market, including forecasts for subscribers. This country databook contains high-level insights into Australia analgesics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia analgesics market report size, by drug type, 2018-2030 (US$M)

Australia Analgesics Market Share, 2022 & 2030 (US$M)

Australia analgesics market report size, by drug type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more